Not applicableEnded earlyNCT01737957What this trial is testingSafety and Efficacy of Low-Fluence PRP for PDRWho this might be right forProliferative Diabetic Retinopathy Asociación para Evitar la Ceguera en México 60
Testing effectiveness (Phase 2)Study completedNCT01280929What this trial is testingProspective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic RetinopathyWho this might be right forHigh Risk Proliferative Diabetic Retinopathy José Cunha-Vaz 54
Large-scale testing (Phase 3)Study completedNCT04278417What this trial is testingStudy of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic RetinopathyWho this might be right forProliferative Diabetic Retinopathy Novartis Pharmaceuticals 689
Not applicableUnknownNCT02911311What this trial is testingConbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic RetinopathyWho this might be right forProliferative Diabetic Retinopathy Sun Yat-sen University 226
Large-scale testing (Phase 3)UnknownNCT01304225What this trial is testingPanretinal Photocoagulation for Diabetic Retinopathy With PASCAL LaserWho this might be right forDiabetic Retinopathy Federal University of São Paulo 60
Large-scale testing (Phase 3)Study completedNCT02705274What this trial is testingPRP vs Bevacizumab for PDR TreatmentWho this might be right forProliferative Diabetic Retinopathy Marashi Eye Clinic 30
Not applicableUnknownNCT01023113What this trial is testingTo Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal PhotocoagulationWho this might be right forMacular EdemaDiabetic RetinopathyVisual Field Loss L.V. Prasad Eye Institute 60
Testing effectiveness (Phase 2)Study completedNCT01594281What this trial is testingMulticenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)Who this might be right forProliferative Diabetic Retinopathy (PDR) Novartis Pharmaceuticals 107
Not applicableLooking for participantsNCT07586787What this trial is testingEarly Vitrectomy vs PRP in Early Proliferative Diabetic RetinopathyWho this might be right forProliferative Diabetic Retinopathy (PDR) Xiamen Ophthalmology Center Affiliated to Xiamen University 100
Large-scale testing (Phase 3)WithdrawnNCT00347698What this trial is testingIntravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Asociación para Evitar la Ceguera en México
Testing effectiveness (Phase 2)Study completedNCT01746563What this trial is testingIntravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic RetinopathyWho this might be right forDiabetic RetinopathyRetinal DiseasesEye Diseases+3 more University of Sao Paulo 30
Testing effectiveness (Phase 2)Study completedNCT00841373What this trial is testingRanibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic DiseaseWho this might be right forRetinal Ischemia Southern New England Retina Associates 1
Not applicableNot Yet RecruitingNCT06649604What this trial is testingReducing Pain From Retinal Laser With Vibrational StimulationWho this might be right forPain, Perioperative University of Alberta 50
Not applicableUnknownNCT04103671What this trial is testingPars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDRWho this might be right forNon Proliferative Diabetic Retinopathy Zhongshan Ophthalmic Center, Sun Yat-sen University 272
Not applicableStudy completedNCT02995629What this trial is testingPatient Comfort Using Green vs. Yellow Pan Retinal PhotocoagulationWho this might be right forProliferative Diabetic Retinopathy - High Risk Wills Eye 40
Not applicableStudy completedNCT02621580What this trial is testingInvestigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy PatientsWho this might be right forDiabetic Retinopathy London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 24
Testing effectiveness (Phase 2)Study completedNCT01281098What this trial is testingProspective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.Who this might be right forHigh Risk Proliferative Diabetic RetinopathyDiabetes Mellitus Type IDiabetes Mellitus Type II Association for Innovation and Biomedical Research on Light and Image 22
Large-scale testing (Phase 3)Study completedNCT01941329What this trial is testingProspective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.Who this might be right forHigh Risk Proliferative Diabetic Retinopathy Association for Innovation and Biomedical Research on Light and Image 94
Post-approval studies (Phase 4)Study completedNCT07640256What this trial is testingPain Management During Panretinal Photocoagulation for Diabetic Retinopathy: Safety and Efficacy of Peribulbar AnesthesiaWho this might be right forProliferative Diabetic Retinopathy Asociación para Evitar la Ceguera en México 50
Testing effectiveness (Phase 2)Study completedNCT04424290What this trial is testingHORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular IschemiaWho this might be right forDiabetic Retinopathy Boehringer Ingelheim 45